Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)

Sunshine Biopharma (SBFM) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 103732.0 as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Liabilities from Discontinued Operations changed N/A year-over-year to 103732.0, compared with a TTM value of 103732.0 through Jun 2019, changed N/A, and an annual FY2018 reading of 103732.0, changed N/A over the prior year.
  • Liabilities from Discontinued Operations was 103732.0 for Q2 2019 at Sunshine Biopharma, roughly flat from 103732.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 103732.0 in Q4 2018 and bottomed at 103732.0 in Q4 2018.